Friedreich’s ataxia is a chronic, progressive neurological condition that leads to impaired muscle coordination. This can affect balance and mobility as well as speech and heart health. Friedreich’s ...

(RTTNews) - Biogen Inc. (BIIB) said that the European Commission has authorized Skyclarys (omaveloxolone) for the treatment of Friedreich's ataxia in adults and adolescents aged 16 years and older.

Eleven-person biotech company Chondrial Therapeutics just raised $25.8 million in a private stock sale to commercialize its treatment for people with the neurodegenerative movement disorder Friedreich ...

Levacetylleucine significantly improves neurological symptoms and functioning in patients with ataxia-telangiectasia, according to results from the IB1001-303 clinical trial. Topline results were ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

People living with a rare neurological degenerative disease have called on the Government to make the first treatment for the ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted priority review to Reata Pharmaceuticals Inc.’s new drug application for omaveloxolone to ...

Phase III trial successfully achieved its primary endpoint and key secondary endpoints with high statistical significance Levacetylleucine demonstrated clinically meaningful improvements in ...

Treatment goals for Friedreich ataxia include symptom management, slowing disease progression, and enhancing quality of life through multidisciplinary care. Supportive therapies address comorbidities ...

NEW YORK, Nov. 8, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders ...

The first time Stephanie Miller heard the word “ataxia” was when she learned she had it. Now the Cleveland woman is doing what she can to slow its progression with a strong support system of family ...